The use of narrow-band imaging to improve pathological margin in oral squamous cell carcinoma: A prospective randomized controlled trial

Phase 2

Recruiting

• Conditions: Oral squamous cell carcinoma patients aged more than 18 years with Eastern Cooperative Oncology Group (ECOG) performance status 0-1 who are due to undergo surgical treatment at Maharaj Nakorn Chiang Mai Hospital between June 2022 and May 2024.; Narrow-band imaging; Resection margin; Oral cancer; Squamous cell carcinoma

• Registration Number: TCTR20240427008
• Lead Sponsor: one

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-04-27
• Study Completion: 2024-05-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 96

Inclusion Criteria

Oral squamous cell carcinoma patients aged more than 18 years with Eastern Cooperative Oncology Group (ECOG) performance status 0-1 who are due to undergo surgical treatment.

Exclusion Criteria

Patients who have previous head and neck surgery or irradiation, extensive lesions unable to define mucosal resection margins around the tumor, distant metastatic disease, and cancer in other parts of the body.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pathological margin status date of pathological report (approximately 2 weeks after surgery) free margin or positive margin

Secondary Outcome Measures

Name	Time	Method
surgical complications 1 month postoperative yes or no,Length of hospital stay discharge date days of hospitalization